Asgard Therapeutics
Biotechnology ResearchView the employees at
Asgard Therapeutics-
Emilie Renaud Senior Scientist Gene Therapy
-
Rising Star
Fritiof Åkerström In vivo Scientist at Asgard Therapeutics AB-
Lund, Skåne County, Sweden
-
Rising Star
Cristiana Pires CEO Asgard Therapeutics | Cell Reprogramming Scientist-
Lund, Kalmar County, Sweden
-
Top 5%
Iveta Mikalajūnaitė Junior Business Developer at Asgard Therapeutics | Bioentrepreneur-
Rising Star
Philipp Mueller Executive Director / Investment Manager - Therapeutics Investment Team at Boehringer Ingelheim Venture Fund-
Biberach an der Riß, Baden-Württemberg, Germany
-
Rising Star
Overview
Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard Therapeutics aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient.
-